Several Medical Device Consultancy Firms Acquired by Veranex
Medical technology company Vernaex, has recently acquired a portfdolio of full service medical device consultancy companies, which provide regulatory and clinical affairs, biocompatibility services and quality assurance for medical devices, as well as IVD (in vitro diagnostic) devices.
Based within Sweden, this portfolio is comprised of Devicia, which is a full service partner which offers clinical expertise, Claryin, which is a provider of strategic guidance for quality assurance and strategic affairs, and also the affiliated companies Lea Reg, Kickfile and Limulus Bio.
Along with a recent acquisition of Medidee, based in Switzerland, these companies mark an expansion of Veranex’sa European reach, building clinical, quality service and regulatory segments. This particularly strengthens Veranex’s MDR (medical device regulation) and IVDR (in vitro diagnostic regulation) strategies, and adds expertise within biological evaluation, as well as software for medical devices, while also expanding their infrastructure, designating more local representation within the EU and the UK, with the ecosystem of companies adding 3 further locations across Europe and the United States to Veranex’s global footprint.
Veranex CEO David Dockhorn said: “This group of companies, led by Devicia and Clarvin, shares the same goal as Veranex: working with our clients to achieve and accelerate medtech innovation. Devicia, Clarvin, and their affiliate companies all focus exclusively on medical devices and IVD, providing strategic guidance and informed execution across a number of areas, including clinical trial, medical writing, regulatory strategies, toxicology assessments, designated local representation, and system technologies that bolster Veranex’s full-service medtech capabilities and solutions.”
Devicia CEO Elisabeth Liljensten said: “We are extremely excited about the opportunity to support clients even more comprehensively with our full-service medical device and IVD services, and a significantly stronger global presence. We strongly believe that a global perspective and broad geographic footprint provides strategic value to market access for our clients.”
Clarvin CEO Åsa Runnäs added: “Since the first interaction with Veranex, we realised we shared the same vision for the best way to help our clients — with a combination of top regulatory intelligence, expert knowledge within different areas, and true global reach.” Veranex’s Financial advisor were A&M (Alvarez and Marsal), and the company’s legal advisor was firm MWE (McDermott Will & Emery). Financial details are not currently being disclosed